In vitro activity of hybrid lavender essential oils against multidrug resistant strains of Pseudomonas aeruginosa

被引:33
|
作者
Donadu, Matthew [1 ]
Usai, Donatella [1 ]
Pinna, Antonio [2 ]
Porcu, Tiziana [2 ]
Mazzarello, Vittorio [1 ]
Fiamma, Maura [1 ,5 ]
Marchetti, Mauro [3 ]
Cannas, Sara [1 ]
Delogu, Giovanni [4 ]
Zanetti, Stefania [1 ]
Molicotti, Paola [1 ]
机构
[1] Univ Sassari, Dept Biomed Sci, Viale San Pietro 43b, I-07100 Sassari, Italy
[2] Univ Sassari, Ophthalmol Unit, Dept Surg Microsurg & Med Sci, Sassari, Italy
[3] Inst Biomol Chem, CNR, Sassari, Italy
[4] Sacro Cuore Catholic Univ, Inst Microbiol, Rome, Italy
[5] Hosp San Francesco, Anal Lab, Nuoro, Italy
来源
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2018年 / 12卷 / 01期
关键词
antimicrobials; biopharmaceuticals; cytotoxicity; infection; Pseudomonads; KERATITIS;
D O I
10.3855/jidc.9920
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Lavender is an evergreen shrub native to Northern Africa and other mountainous Mediterranean regions. It grows throughout Southern Europe, the United States, and Australia. Lavender essential oil has been used since ancient times and is known for its anti-inflammatory, antidepressant, antiseptic, antifungal and antimicrobial properties. Methodology: in this study, the antimicrobial activity of two Lavender essential oils (Lavanda sumian and Lavanda grosso) against 16 multidrug-resistant P. aeruginosa strains from clinical ocular samples taken from migrant patients has been investigated. The in vitro cytotoxic activity on human Wong-Kilbourne derivative (WKD) conjunctiva cells from healthy patients and nitric oxide synthase (NOS) activity on murine macrophage (J774.1A) were also evaluated. Results: L. sumian showed lower antimicrobial activity when compared to L. grosso. Both lavender oils tested had no cytotoxic effect at very low concentrations, mostly L. grosso. The essential oils extracted from L. sumian and L. grosso significantly reduced NOS in a cell model. Conclusion: Increase in drug resistance and lack of new antibiotics may encourage the development of natural antimicrobial treatments.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [41] Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains
    Warawa, Jonathan M.
    Duan, Xiaoxian
    Anderson, Charles D.
    Sotsky, Julie B.
    Cramer, Daniel E.
    Pfeffer, Tia L.
    Guo, Haixun
    Adcock, Scott
    Lepak, Alexander J.
    Andes, David R.
    Slone, Stacey A.
    Stromberg, Arnold J.
    Gabbard, Jon D.
    Severson, William E.
    Lawrenz, Matthew B.
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [42] In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa
    GarciaRodriguez, JA
    Blazquez, AM
    Fresnadillo, MJ
    Sanchez, EG
    Sanchez, JEG
    Martin, IT
    JOURNAL OF CHEMOTHERAPY, 1996, 8 (05) : 358 - 364
  • [43] In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
    Malisova, Lucia
    Vrbova, Iveta
    Pomorska, Katarina
    Jakubu, Vladislav
    Zemlickova, Helena
    MICROBIAL DRUG RESISTANCE, 2023, 29 (10) : 485 - 491
  • [44] Antimicrobial activity of different Lactobacillus species against multidrug resistant clinical isolates of Pseudomonas aeruginosa
    Jamalifar, H.
    Rahimi, H. R.
    Samadi, N.
    Shahverdi, A. R.
    Sharifian, Z.
    Hosseini, F.
    Eslahi, H.
    Fazeli, M. R.
    IRANIAN JOURNAL OF MICROBIOLOGY, 2011, 3 (01) : 21 - 25
  • [45] Bactericidal Activity in Filtrated Supernatant of Streptococcus Sanguinis against Multidrug-Resistant Pseudomonas Aeruginosa
    Watanabe, Kiwao
    Senba, Masachika
    Ichinose, Akitoyo
    Yamamoto, Takeshi
    Ariyoshi, Koya
    Matsumoto, Keizo
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 219 (02): : 79 - 84
  • [46] In Vitro Antibiofilm Activity of Fosfomycin Alone and in Combination with Other Antibiotics against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa
    Slade-Vitkovic, Mia
    Batarilo, Ivanka
    Bielen, Luka
    Maravic-Vlahovicek, Gordana
    Bedenic, Branka
    PHARMACEUTICALS, 2024, 17 (06)
  • [47] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
    Hu, Yi-Fan
    Liu, Chang-Pan
    Wang, Nai-Yu
    Shih, Shou-Chuan
    BMC INFECTIOUS DISEASES, 2016, 16
  • [48] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
    Yi-Fan Hu
    Chang-Pan Liu
    Nai-Yu Wang
    Shou-Chuan Shih
    BMC Infectious Diseases, 16
  • [49] Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa In Vitro and In Vivo
    Moustafa, Dina A.
    Wu, Ashley W.
    Zamora, Danniel
    Daly, Seth M.
    Sturge, Carolyn R.
    Pybus, Christine
    Geller, Bruce L.
    Goldberg, Joanna B.
    Greenberg, David E.
    MBIO, 2021, 12 (01): : 1 - 12
  • [50] In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas Aeruginosa
    Carr, Donna
    Zhang, Zufei
    Si, Qian
    Racine, Fred
    Xiao, Jing Chen
    Katwaru, Ravi
    Wismer, Michael K.
    Johnson, Matthew G.
    Feng, Hwa-Ping
    Young, Katherine
    Rizk, Matthew L.
    Motyl, Mary
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (11):